TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: KEGG pathway enrichment analysis of the differentially expressed ncRNAs was conducted in the high‐ and low‐risk groups, and five significantly enriched pathways were obtained in the high‐risk group, including glioma, the p53 signaling pathway, ubiquitin‐mediated proteolysis, cell cycle and chronic myeloid leukemia.